NEU 3.15% $21.27 neuren pharmaceuticals limited

neu investor presentation, page-21

  1. 144 Posts.
    Hi cortinaboy - I have stated an opinion, and it is based not on complete factual knowledge, but my opinionated guesses.

    On my first point, I am already assuming that the primary endpoint (safety) will be a given (i.e. no safety issues).

    On the second point, my opinionated 'inevitability' about the US Army trial success comes from an observation that they are funding a trial for mild TBI whilst already conducting a moderate to severe TBI for at least the last 2-3 years. My opinion again is that they wouldn't release funds for 2 trials on the same drug (when the first trial isn't over) if they didn't have some 'confidence' with it.

    You provide a great balance on this forum by being objective and stating evidence based probabilities - I am one of the posters because of whom we will need you to provide that balance.

    For me, commentary without speculative exuberance for 'blue-sky' stocks would just not be exciting enough :)

    Regards

    Jim
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.